New anticoagulants & clinical trials.
This article reviews for early 2009 the pharmacology and indications of approved newer anticoagulants and also briefly reviews agents being tested in clinical trials.
Haideri
Nisreen
N
Division of Hematology and Oncology, University of Missouri-Kansas City School of Medicine, USA.
Patel
Hitendra
H
D000925:Anticoagulants / Q000627:therapeutic use*; D001777:Blood Coagulation; D001779:Blood Coagulation Factors; D065427:Factor Xa Inhibitors; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D011956:Receptors, Cell Surface; D013917:Thrombin / Q000037:antagonists & inhibitors; D013923:Thromboembolism / Q000188:drug therapy*; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D001779:Blood Coagulation Factors; D065427:Factor Xa Inhibitors; D006495:Heparin, Low-Molecular-Weight; D011956:Receptors, Cell Surface; C091963:activated protein C receptor; D014859:Warfarin; D013917:Thrombin